loadpatents
Patent applications and USPTO patent grants for BUCK; Ildiko Maria.The latest application filed is for "bicyclic heterocycle compounds and their uses in therapy".
Patent | Date |
---|---|
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20220204503 - CHESSARI; Gianni ;   et al. | 2022-06-30 |
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20220106287 - CHESSARI; Gianni ;   et al. | 2022-04-07 |
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 11,261,171 - Chessari , et al. March 1, 2 | 2022-03-01 |
Bicyclic heterocycle compounds and their uses in therapy Grant 11,225,476 - Chessari , et al. January 18, 2 | 2022-01-18 |
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20210276984 - CHESSARI; Gianni ;   et al. | 2021-09-09 |
Benzolactam compounds as protein kinase inhibitors Grant 11,001,575 - Berdini , et al. May 11, 2 | 2021-05-11 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20210122749 - WOOLFORD; Alison Jo-Anne ;   et al. | 2021-04-29 |
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,981,898 - Chessari , et al. April 20, 2 | 2021-04-20 |
Pharmaceutical Compounds App 20210107908 - JOHNSON; Christopher Norbert ;   et al. | 2021-04-15 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20200325134 - CHESSARI; Gianni ;   et al. | 2020-10-15 |
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200247789 - Kind Code | 2020-08-06 |
Bicyclic heterocycle compounds and their uses in therapy Grant 10,618,895 - Chessari , et al. | 2020-04-14 |
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,544,132 - Chessari , et al. Ja | 2020-01-28 |
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 10,526,311 - Chessari , et al. J | 2020-01-07 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20190375748 - WOOLFORD; Alison Jo-Anne ;   et al. | 2019-12-12 |
Benzolactam compounds as protein kinase inhibitors Grant 10,457,669 - Berdini , et al. Oc | 2019-10-29 |
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190055215 - CHESSARI; Gianni ;   et al. | 2019-02-21 |
Benzolactam Compounds As Protein Kinase Inhibitors App 20190047990 - BERDINI; Valerio ;   et al. | 2019-02-14 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20180065959 - CHESSARI; Gianni ;   et al. | 2018-03-08 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20170334907 - WOOLFORD; Alison Jo-Anne ;   et al. | 2017-11-23 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,783,538 - Chessari , et al. October 10, 2 | 2017-10-10 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,676,768 - Woolford , et al. June 13, 2 | 2017-06-13 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,617,283 - Chessari , et al. April 11, 2 | 2017-04-11 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,617,248 - Chessari , et al. April 11, 2 | 2017-04-11 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20170029419 - CHESSARI; Gianni ;   et al. | 2017-02-02 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,458,158 - Buck , et al. October 4, 2 | 2016-10-04 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20160083377 - BUCK; Ildiko Maria ;   et al. | 2016-03-24 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20150353537 - CHESSARI; Gianni ;   et al. | 2015-12-10 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20150291586 - WOOLFORD; Alison Jo-Anne ;   et al. | 2015-10-15 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,155,743 - Buck , et al. October 13, 2 | 2015-10-13 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20150259359 - Chessari; Gianni ;   et al. | 2015-09-17 |
Bicyclic heterocycle compounds and their uses in therapy Grant 9,018,214 - Woolford , et al. April 28, 2 | 2015-04-28 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20140179666 - Woolford; Alison Jo-Anne ;   et al. | 2014-06-26 |
Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20140045831 - Buck; Ildiko Maria ;   et al. | 2014-02-13 |
Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands App 20070185093 - Buck; Ildiko Maria ;   et al. | 2007-08-09 |
Gastrin and cholecystokinin receptor ligands (III) Grant 7,034,048 - Kalindjian , et al. April 25, 2 | 2006-04-25 |
Benzotriazepnes as gastrin and cholecystokinin receptor ligands App 20060003993 - McDonald; Iain Mair ;   et al. | 2006-01-05 |
Histamine H3 receptor ligands Grant 6,878,736 - Kalindjian , et al. April 12, 2 | 2005-04-12 |
Gastrin and cholecystokinin receptor ligands(II) Grant 6,878,734 - Kalindjian , et al. April 12, 2 | 2005-04-12 |
Gastrin and cholecystokinin receptor ligands(II) App 20030199565 - Kalindjian, Sarkis Barret ;   et al. | 2003-10-23 |
Gastrin and cholecystokinin receptor ligands (III) App 20030191116 - Kalindjian, Sarkis Barret ;   et al. | 2003-10-09 |
Gastrin and cholecystokinin receptor ligands Grant 6,479,531 - Kalindjian , et al. November 12, 2 | 2002-11-12 |
Gastrin and cck receptor ligands Grant 5,919,829 - Kalindjian , et al. July 6, 1 | 1999-07-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.